Neonatal alloimmune thrombocytopenia (NAIT) is a condition that occurs when a mother’s immune system produces antibodies against her baby's platelets, leading to low platelet counts in the newborn.
today announced the initiation of its Phase 2 clinical trial investigating RLYB212 in pregnant women at higher risk for HPA-1a alloimmunization and fetal and neonatal alloimmune thrombocytopenia ...
The study offers hope for the effective treatment of alloimmunisation. Another immunisation disorder in the fetus and newborn is fetal/neonatal alloimmune thrombocytopenia (FNAIT). The mother forms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback